Antirheumatic Agents.
[No authors listed]
2021 Oct 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Kidney Disease in Ankylosing Spondylitis: a case series and review of the literature.
Rodrigues AC, Marques JC, Reis M, Góis M, Sousa H, Nolasco F.
J Bras Nefrol. 2023 Jan-Mar;45(1):36-44. doi: 10.1590/2175-8239-JBN-2022-0008.
Interleukin Receptor Antagonists.
[No authors listed]
2021 Sep 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Tumor Necrosis Factor Antagonists.
[No authors listed]
2017 Feb 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Efficacy and safety of ultrasound-guided percutaneous nephrolithotomy for kidney calculi patients with ankylosing spondylitis: a retrospective single center analysis.
Xia M, Hong Y, An L, Xiong L, Huang X, Xu Q.
Ann Palliat Med. 2021 May;10(5):5252-5259. doi: 10.21037/apm-20-2304. Epub 2021 Apr 25.
Biologics for the treatment of autoimmune renal diseases.
Holdsworth SR, Gan PY, Kitching AR.
Nat Rev Nephrol. 2016 Apr;12(4):217-31. doi: 10.1038/nrneph.2016.18. Epub 2016 Mar 7.
Assessment of liver and kidney function in patients with ankylosing spondylitis on long-term non-steroidal anti-inflammatory drug therapy.
Sülükcü S, Uslu S.
Reumatismo. 2024 Sep 24. doi: 10.4081/reumatismo.2024.1732. Online ahead of print.
Ankylosing spondylitis in patients undergoing total hip arthroplasty increases the risk of medical and implant-related complications: a case control analysis.
Mekkawy KL, Rodriguez HC, Mercadal G, Gosthe RG, Khanuja HS, Corces A, Roche MW.
Hip Int. 2024 Sep;34(5):602-607. doi: 10.1177/11207000241267706. Epub 2024 Aug 16.
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics.
Li P, Zheng Y, Chen X.
Front Pharmacol. 2017 Jul 12;8:460. doi: 10.3389/fphar.2017.00460. eCollection 2017.
Rituximab as possible therapy in TNF inhibitor-induced IgA vasculitis with severe renal involvement.
Przygocka A, Berti GM, Campus A, Tondolo F, Vischini G, Fabbrizio B, La Manna G, Baraldi O.
BMC Nephrol. 2023 Dec 20;24(1):381. doi: 10.1186/s12882-023-03439-0.
